We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Protein Found Essential for Brain Development

By Biotechdaily staff writers
Posted on 18 Jun 2003
Researchers have found that the 14-3-3 epsilon protein, one of a family of ubiquitous phosphoserine/threonine-binding proteins, is required for normal brain development, and when a mutation causes a deficiency of this protein, the result is the serious brain disorder known as lissencephaly.

Lissencephaly, which literally means "smooth brain,” is a rare brain formation disorder characterized by the lack of normal convolutions in the brain and an abnormally small head (microcephaly) caused by defective neuronal migration. More...
Lissencephaly may be associated with other diseases, including isolated lissencephaly sequence, Miller-Dieker syndrome (MDS), and Walker-Warburg syndrome.

LIS1 (which stands for Lissencephaly-1) is a gene that is deleted or mutated on a chromosomal region of chromosome 17 (called 17p13.3) in many children with lissencephaly. LIS1 resides fairly close to the 14-3-3 epsilon gene on this chromosome. Patients with lissencephaly only have deletions of one copy of LIS1, but never 14-3-3 epsilon, while patients with MDS have deletions of both genes on the same chromosome.

In a new study published June 8, 2003, in the online edition of Nature Genetics, investigators at the University of California, San Diego (USA; www.uscd.edu), established a crucial role for 14-3-3 epsilon in neuronal development in sustaining the effects of CDK5 phosphorylation and provided a molecular explanation for the differences in severity of human neuronal migration defects with 17p13.3 deletions.

Senior author Dr. Anthony Wynshaw-Boris explained, "This is the first demonstration in mammals that 14-3-3 epsilon is essential for brain development. We also showed that the gene is always deleted on one chromosome in patients with a rare but severe brain disorder called Miller-Dieker syndrome (MDS). Not only does our study determine a novel function for 14-3-3 epsilon, but it also provides a molecular explanation for why MDS patients have more severe lissencephaly.”



Related Links:
University of California, San Diego

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.